<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article151</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/RESPECT" style="display:block; margin-bottom:10px;">RESPECT Original</a></li>
<h2><strong>RESPECT</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "PFO Closure vs. Medical Therapy in Stroke Prevention". The New England Journal of Medicine. 2013.<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
Does patent foramen ovale (PFO) closure reduce the risk of recurrent ischemic stroke compared to medical therapy alone in patients 18 to 60 years of age with a history of cryptogenic stroke?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
In patients who had a cryptogenic ischemic stroke and a PFO, closure with the Amplatzer PFO Occluder device did not show a significant benefit over medical therapy alone in the primary intention-to-treat analysis. However, PFO closure was found to be superior to medical therapy alone in the prespecified per-protocol and as-treated analyses, with a low rate of associated risks.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/><br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
Current guidelines do not provide specific recommendations for PFO closure in patients with a cryptogenic stroke due to the mixed evidence from trials.<br/>
<br/>
<h2><strong>Design</strong></h2><br/>
Prospective, multicenter, randomized, event-driven trial comparing PFO closure to medical therapy alone.<br/>
N=980 patients enrolled at 69 sites.<br/>
Patients were 18 to 60 years of age with a history of cryptogenic ischemic stroke.<br/>
Randomization to PFO closure with the Amplatzer PFO Occluder or medical therapy only.<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
Inclusion Criteria:<br/>
- 18 to 60 years of age<br/>
- Cryptogenic ischemic stroke<br/>
- PFO identified via transesophageal echocardiography<br/>
<br/>
Exclusion Criteria:<br/>
- Identifiable causes of stroke apart from paradoxical embolism<br/>
- Significant shunt or atrial septal defect<br/>
- Hypercoagulable states<br/>
<br/>
Baseline Characteristics:<br/>
- Mean age: 45.9 years<br/>
- 51.4% female<br/>
- Median follow-up: 2.1 years<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
- PFO closure within 21 days after randomization<br/>
- Medical therapy allowed: aspirin, warfarin, clopidogrel, or combined aspirin with extended-release dipyridamole<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
Primary Outcomes:<br/>
- Recurrent nonfatal ischemic stroke, fatal ischemic stroke, or early death after randomization<br/>
<br/>
Secondary Outcomes:<br/>
- Complete closure of PFO on the 6-month follow-up transesophageal echocardiogram<br/>
- Absence of recurrent symptomatic nonfatal ischemic stroke or cardiovascular death<br/>
- Absence of a transient ischemic attack<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
- Higher dropout rate in the medical-therapy group leading to unequal duration of exposure to the risk of recurrence<br/>
- The primary analysis not showing superiority of PFO closure<br/>
- Long-term protective benefit of closure remains uncertain due to modest absolute event reduction<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
The study was funded by St. Jude Medical.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/><p></p>
</div>
</div>
</div>
</div>
</body>
</html>
